74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
West Pharmaceutical Services Inc
Closed
SectorHealthcare
213.46 -1.33
Overview
Share price change
24h
Min
213.25
Max
216.74
Income | -40M 90M |
|---|---|
Sales | -51M 698M |
P/E Sector Avg | 33.928 56.294 |
EPS | 1.45 |
Dividend yield | 0.39 |
Profit margin | 12.865 |
Employees | 10,600 |
EBITDA | -98M 107M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +31.87% upside |
Dividend yield Sector Avg | 0.39% 2.55% |
|---|---|
Next Earnings | 24 Jul 2025 |
Next Dividend date | 7 May 2025 |
Next Ex Dividend date | 30 Apr 2025 |
Market Cap | 178M 16B |
|---|---|
Previous open | 214.79 |
Previous close | 213.46 |
Technical Score
By Trading Central
Confidence
Strong Bullish Evidence
West Pharmaceutical Services Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
West Pharmaceutical Services Inc Forecast
Price Target
By TipRanks
31.87% upside
12 Months Forecast
Average 285 USD 31.87%
High 370 USD
Low 245 USD
Based on 9 Wall Street analysts offering 12 month price targets forWest Pharmaceutical Services Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
